The median numbers of tumor-infiltrating CD8+ T cells and Tregs in the primary cohort were 9.0 (IQR 3.3-23.6) and 16.0 (IQR 10.0-27.0), respectively (Table 1; Figure 3A). This evidence concerns the gene CD8A and neoplasm.